Syensqo - First Quarter 2025 Results

In This Article:

Syensqo SA
Syensqo SA

SYENSQO FIRST QUARTER 2025 RESULTS

NET SALES OF €1.62 BILLION LED BY COMPOSITE MATERIALS, TECHNOLOGY SOLUTIONS & NOVECARE
RESILIENT UNDERLYING EBITDA OF €311 MILLION, UP 5% SEQUENTIALLY
FY 2025 OUTLOOK UNCHANGED

Register to the webcast scheduled at 14:00 CEST - Financial report - Financial calendar

Q1 2025 Highlights

  • Net sales of €1.6 billion were approximately flat year-on-year, due to lower volumes (-1%) while pricing remained stable; Double digit year-on-year growth in Composite Materials & Technology Solutions; On a sequential basis, net sales increased by 1%, driven by higher pricing (1%) while volumes remained stable;

  • Gross profit of €514 million decreased by 12% year-on-year, primarily driven by unfavorable mix and lower volumes, resulting in gross margin of 31.7%; On a sequential basis, gross profit increased by 7% and gross margin expanded by 160 basis points;

  • Underlying EBITDA of €311 million decreased by 15% year-on-year organically, primarily due to lower EBITDA in Specialty Polymers, partially offset by higher EBITDA in Technology solutions. On a sequential basis, underlying EBITDA increased by 5%;

  • Underlying EBITDA margin contracted by 310 basis points year-on-year, but increased by 60 basis points sequentially to 19.2%;

  • Underlying net profit of €100 million;

  • Operating cash flow of €176 million; Free cash flow of €37 million impacted by the phasing of capital expenditures;

  • Share buyback program: repurchased c. 758,000 shares, or €56 million.

Underlying (€ million)

Q1 2025

Q1 2024

Q4 2024

YoY change

YoY organic

QoQ change

Net sales

1,619

1,624

1,598

-0.3%

-1.4%

1.3%

Gross profit

514

583

482

-11.9%

-

6.5%

Gross profit margin

31.7%

35.9%

30.2%

-420 bps

-

160 bps

Underlying EBITDA

311

363

298

-14.2%

-15.1%

4.5%

Underlying EBITDA margin

19.2%

22.3%

18.6%

-310 bps

-310 bps

60 bps

Operating cash flow

176

244

345

-27.9%

-

-49.1%

Free cash flow

37

157

159

n.m.

-

n.m.

Cash conversion (LTM)

68%

89%

71%

n.m.

-

n.m.

Cash conversion (LTM) excl. €167mn payment to NJDEP in Q2'24

80%

89%

82%

-850 bps

-

-190 bps

ROCE (LTM)

7.1%

9.6%

7.9%

-250 bps

-

-80 bps

Dr. Ilham Kadri, CEO

“The first quarter saw us deliver on our outlook, driven by double digit year-on-year revenue growth in Composite Materials and Technology Solutions as well as robust growth in Novecare. As expected, Specialty Polymers performance reflected the previously announced headwinds in Electronics; however, we continued to deliver resilient underlying margins supported by positive overall net pricing and disciplined cost control.